CERVICO-FACIAL HEMANGIOMAS; THE TREATMENT THAT ELUDES US

S.M. Sharma

doi:10.1055/s-0040-1703511

Journal of Health and Allied Sciences NU, Table of Contents

CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2011; 01(01/03): 02-09
DOI: 10.1055/s-0040-1703511

Original Article

CERVICO-FACIAL HEMANGIOMAS; THE TREATMENT THAT ELUDES US

S.M. Sharma

Professor & H.O.D, Dept. of Oral and Maxillo Facial Surgery A.B. Shetty Memorial Institute of Dental Sciences, Nitte University, Deralakatte, Mangalore - 575 018

› Author Affiliations

Abstract

PDF Download

Abstract

Cervicofacial hemangiomas treated from January 2001 to December 2009 was clinically evaluated. This retrospective clinical study consisted of 42 females and 20 males with the age ranged from 20 days to 55 years. The lesions were present with-in first month in 45 patients (72.6%). Two patterns of tumor growth were evident: focal and diffuse. There were 59 focal hemangiomas (80.8%) and 14 diffuse hemangiomas (19.2%). Complications noted at the time of first consultation include residual skin changes in the in 35 patients (56.5%), obstruction of orifices in 14 patients (22.6%), ulceration in 6 patients (9.7%), and infection occurred in 2 patients (3.2%). Overall, there is reduction in size and improvement in color and texture of lesion following intervention in each group. No significant difference in outcome was observed in between groups with respect to change in size and texture. However, improvement in color showed statistically significant difference and combined treatment modality and surgical treatment was found to be better.

Keywords

Hemangioma - cervicofacia - management - challenges in treatment

PDF (178 kb)

References

References
1 Mulliken JB, Young AE. Vascular birthmarks: hemangiomas and malformations. Philadelphia: Saunders; 1988.
2 Mulliken JB, Glowacki J. Hemangiomas & vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-20.
3 Pratt AG. Birthmarks in infants. Arch Dermatol 1967;67:302-305.
4 Jacobs AH, Walton RG. The incidence of birthmarks in the neonates. Pediatrics 1976;58:218-222.
5 Holmdahl K. Cutaneous hemangiomas in premature and young infants. Acta Paediatr Scand 1955;44:370-9.
6 Jacobs AH. Strawberry hemangioma: The natural history of the untreated lesion. Calif Med. 1957;86: 8–10.
7 Amir J, Metzker A, Krikler R. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331–332.
8 Hidano A, Nakajima S. Earliest features of the strawberry mark in the newborn. Br J Dermatol 1972;87:138-144.
9 Bowers, R. E., Graham, E. A., and Tomlinson, K. M. The natural history of the strawberry nevus. Arch Dermatol 1960;82:667-80.
10 Cheung, D. S., Warman, W. L., and Mulliken, J. B. Hemangioma in twins. Ann Plast Surg 1997;38:269-74.
11 Enjolras, O., and Gelbert, F. Superficial hemangiomas: Associations and management. Pediatr. Dermatol 1997;14:173-9.
12 Bivings L. Spontaneous regression of angiomas in children: twenty-two years observation covering 236 cases. J Pediatr 1954;45:643-647.
13 Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. Journal of Pediatric Surgery 1983;18:894-900.
14 Dieterich-Miller CA, Cohen BA, Liggett J. Behavioral adjustment and selfconcept of young children with hemangiomas. Pediatr Dermatol 1992;9:241-245.
15 Williams EF, Hochman M, Rodgers BJ, Brockbank D, Shannon L, Lam S. A psychological profile of children and families afflicted with hemangiomas. Arch Facial Plast Surg. 2003;5:229-234.
16 Williams EF, Stanislaw P, Dupree M, Mourtizkos K, Mihm M, Shannon L. Hemangiomas in infants and children: an algorithm for intervention. Arch Facial Plastic Surgery 2000;2:103-111.
17 Frieden IJ, Eichenfield LF, Esterly NB, et al. American Academy of Dermatology guidelines of care for hemangiomas of infancy. J Am Acad Dermatol 1997;37:631-637.
18 Miller SH, Smith RL, Shochat SJ. Compression treatment of hemangiomas. Plast Reconstr Surg 1976;58:573-9.
19 Katz HP. Thrombocytopenia associated with hemangiomata: Critical analysis of steroid therapy. In XI International Congress of Pediatrics. Tokyo 1965:336-337.
20 Zarem HA, Edgerton MT. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967;39:76-83.
21 Bennett ML, Fleischer AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas. An evidence based evaluation. Arch Dermatol 2001;137:1208-1213.
22 Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 1996;128:141-146.
23 Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangiomas. J Coll Physicians Surg Pak 2006;16:662–5.
24 Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007;119:e1239–47.
26 Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. Journal of Pediatric Surgery 2000;35(3):420-423.
27 Garzon MC, Lucky AW, Hawrot A, Frieden IJ. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol 2005;52:281-6.
28 Kane WJ, Morris S, Jackson IT, Woods JE. Significant hemangiomas & vascular malformations of the head & neck: Clinical management and treatment outcomes. Annals of Plastic Surgery 1995;35:133-143.
30 Waldorf HA, Lask GP, Geronemus RG. Laser treatment of telangiectasias. In: Alster TS, Apelfberg DB, eds. Cosmetic Laser Surgery. New York: Wiley-Liss; 1996:93–109.
31 Waner M, Suen JY, Dinehart S. Treatment of hemangiomas of the head and neck. Laryngoscope 1992;102:1123-1132.
32 Fawcett SL, Grant I, Hall PN, et al: Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57:168-171.
33 Metz BJ, Rubenstein MC, Levy ML, Metry DW. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet derived growth factor. Arch Dermatol 2004;140:867–870.
34 Leaute-Labreze C, Dumas de la Roque E et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649–2651.
35 Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT (2010). Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope 2009;119(10):2051-54.
36 Popescu V. Intratumoral ligation in the management of orofacial cavernous hemangiomas. Journal of Maxillofacial Surgery 1985;13:99-107.
37 Oji C, Chukwuneke F, Mgbor N. Tobacco-pouch suture technique for the treatment of vascular lesions of the lip in Enugu, Nigeria. British Journal of Oral and Maxillofacial Surgery 2006;44:245–247.
38 Pitanguy I, Machado BH, Radwanski HN, Amorim NF. Surgical treatment of hemangiomas of the nose. Ann Plast Surg 1996;36(6):586-592.
39 Faguer K, Dompmartin A, Labbe´ D, Barrellier MT, Leroy D, Theron J. Early surgical treatment of Cyrano-nose haemangiomas with Rethi incision. Br J Plast Surg 2002;55(6):498-503.
40 Waner M, Kastenbaum J, Scherer K. Hemangiomas of the nose: Surgical management using modified subunit approach. Arch Facial Plast Surg 2008;10(5):329-334.
41 Zide BM, Glat PM, Stile FL, Longaker MT. Vascular lip enlargement, I: hemangiomas–tenets to therapy. Plast Reconstr Surg 1997;100:1664- 1673.
42 Mulliken JB, Rogers GF, Marler JJ. Circular excision of hemangioma and purse-string closure: the smallest possible scar. Plast Reconstr Surg 2002;109:1544–1554.
43 Mcheika JN, Renauldb V, Duportb G, Vergnesc P, Levarda G. Surgical treatment of haemangioma in infants. British Journal of Plastic Surgery 2005;58:1067–1072.
44 Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg 1997;99(5):1301-1308.
45 Demiri EC, Pelissies P, Genin-Etcheberry T, Tsakoniatis N, Martin D, Baudet J. Treatment of facial haemangiomas: the present status of surgery. British Journal of Plastic Surgery 2001;54:665-674.
46 Waner M, North PE, Scherer KA, et al. The non-random distribution of facial hemangiomas. Arch Dermatol 2003;139:869-875.
47 Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006;117:698-703.